LBT Innovations (ASX:LBT) EBIT : A$-18.10 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations EBIT?

LBT Innovations's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was A$-1.81 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-18.10 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. LBT Innovations's annualized ROC % for the quarter that ended in Dec. 2023 was -72.17%. LBT Innovations's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -157.58%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. LBT Innovations's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -98.24%.

LBT Innovations EBIT Historical Data

The historical data trend for LBT Innovations's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBT Innovations EBIT Chart

LBT Innovations Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT

Get a 7-Day Free Trial

-5.98

-7.30

-9.39

-8.66

-20.41

LBT Innovations Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															-4.76	-3.89	-4.13	-16.29	-1.81

Competitive Comparison of LBT Innovations's EBIT

For the Medical Devices subindustry, LBT Innovations's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LBT Innovations's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LBT Innovations's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LBT Innovations's EV-to-EBIT falls into.

LBT Innovations EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-18.10 Mil.

LBT Innovations (ASX:LBT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

LBT Innovations's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-4.098 * ( 1 - 14.71% )	/	( (5.553	+	4.133)	/ 2 )
=	-3.4951842	/	4.843
=	-72.17 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	7.37	-	1.165	-	( 2.02	-	max(0, 4.189	-	4.841	+	2.02	))
=	5.553

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8.125	-	0.75	-	( 3.242	-	max(0, 1.253	-	5.654	+	3.242	))
=	4.133

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

LBT Innovations's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-3.622	/	( ( (1.673 + max(-0.336, 0))	+	(1.553 + max(1.371, 0)) )	/	2 )
=	-3.622	/	( ( 1.673	+	2.924 )	/	2 )
=	-3.622	/	2.2985
=	-157.58 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.32	+	1.49	+	0.849)	-	(1.165	+	0.291	+	1.539)
=	-0.336

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.58	+	1.515	+	0.317)	-	(0.75	+	0	+	0.291)
=	1.371

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

LBT Innovations's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-18.097	/	18.421
	=	-98.24 %

LBT Innovations EBIT Related Terms

Thank you for viewing the detailed overview of LBT Innovations's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

LBT Innovations (ASX:LBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Anster Street, Adelaide, SA, AUS, 5000

Website

https://www.lbtinnovations.com

LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines